<DOC>
	<DOCNO>NCT00844948</DOCNO>
	<brief_summary>This Phase II SBIR study replicate pilot study method establish computer-automated method assess depression severity use interactive voice response system technology demonstrate feasibility obtain measure depression severity treatment response vocal acoustic analysis speech sample obtain telephone . The study automate vocal acoustic analysis method , evaluate applicability patient population ( non-English speaker , children/young adult , geriatric ) , develop multivariate acoustic model enhance biomarker sensitivity treatment response prediction response likelihood individual patient .</brief_summary>
	<brief_title>Vocal Acoustic Biomarkers Depression</brief_title>
	<detailed_description>This study incorporate IVR data collection procedure develop prior pilot study multi-site industry-sponsored Phase 4 randomize , double-blind , placebo-controlled study ( NCT00406952 ) use establish antidepressant therapeutically efficacious dose . The analytic procedure use extract vocal acoustic measure automate facilitate near rapid turn around speech sample acquisition delivery biomarker outcomes data . Multivariate model vocal acoustic information enhance sensitivity treatment response measurement prediction patient response likelihood refine . A total 150 subject recruit proposed study , sample 50 three target depressed patient population - young adult ( 18-25 year old ) , elderly patient ( 60 year old ) , recent Asian immigrant financial , linguistic , cultural barrier health care access . Eligible subject meet diagnostic criterion Major Depressive Disorder , provide write informed consent , baseline depression severity score 10 great QIDS . Pregnant woman , woman child bear potential use medically accept mean contraception , suicidal homicidal patient , unstable medical illness include cardiovascular , hepatic , renal , respiratory , endocrine , neurological , hematological disease , clinical laboratory evidence hypothyroidism exclude . Patients begin new treatment depression clinically evaluate ( QIDS-C ) face-to-face interview begin treatment ( Baseline ) , follow 4 ( study midpoint ) 8 week later ( end-point ) . After complete clinical interview study participant complete series IVR-based assessment use standard desktop touch-tone telephone .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>1 . Age 18 80 . 2 . Written informed consent . 3 . Current MDD accord fourth version Diagnostic Statistical Manual Mental Disorders ( DSMIV ) 4 . Recently start receive start receive treatment MDD 5 . Quick Inventory Depressive Symptomatology ClinicianRated ( QIDSC ) QIDSIVR score equal great 10 baseline visit . 1 . Subjects suicidal ideation outpatient treatment determine unsafe study clinician . These patient immediately refer appropriate clinical treatment . 2 . History current diagnosis follow DSMIV psychiatric illness : organic mental disorder , schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder otherwise specify , bipolar disorder , patient mood congruent mood incongruent psychotic feature , patient substance dependence disorder , alcohol , active within last 12 month . 3 . History current diagnosis dementia . 4 . Diagnosis history hypothyroidism .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Depression</keyword>
</DOC>